Furthermore, progressive loss of NRF2 activity was seen with aging, which may be explained by studies showing that the expression of NRF2 positive regulators P62 and BRCA1 decreased with age, while NRF2 negative regulators, KEAP1 and BACH1, increased with age [113]
In healthy people, postprandial GIP levels are approximately 4-fold higher than GLP-1 levels
1 The tirzepatide label goes further, naming acute renal failure and flagging that older people may be more susceptible
Below, across-subjects results are reported as (mean (median) SD)
This is where appetite suppression typically becomes noticeable for most people
I think if were serious about utilizing something like this as a lifesaving measure for folks, access has to be a consideration